Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 37Lung Neoplasms 21Brain Neoplasms 21Prostatic Neoplasms 20Pancreatic Neoplasms 20Neoplasm Metastasis 20Carcinoma, Hepatocellular 17Melanoma 15Breast Neoplasms 12Squamous Cell Carcinoma of Head and Neck 8Carcinoma, Renal Cell 8Neoplasms 7Small Cell Lung Carcinoma 6Liver Neoplasms 6Glioblastoma 6Sarcoma 5Head and Neck Neoplasms 4Salivary Gland Neoplasms 3Recurrence 3Kidney Neoplasms 3Gliosarcoma 3Glioma 3Colorectal Neoplasms 3Colonic Neoplasms 3Cholangiocarcinoma 3Adenocarcinoma of Lung 3Uveal Melanoma 2Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Sarcoma, Ewing 2

Interventions

Sunitinib 3pembrolizumab 2pazopanib 2Axitinib 2aldesleukin 1Radiosurgery 1Nivolumab 1Nephrectomy 1Metastasectomy 1LY2510924 1Ipilimumab 1Interleukin-2 1Immunoglobulin G 1Cytoreduction Surgical Procedures 1Ascorbic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Clear-cell metastatic renal cell carcinoma × Radiosurgery × Clear all
NCT01896271 2021-08-23

High Dose IL-2 and Stereotactic Ablative Body Radiation Therapy for Metastatic Renal Cancer

University of Texas Southwestern Medical Center

Phase 2 Completed
30 enrolled 12 charts
Genitourinary

Clear-cell metastatic renal cell carcinoma, Kidney Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡